Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03877588
What this trial is testing

Nutritional Status in Retroperitoneal Sarcoma.

Who this might be right for
Retroperitoneal SarcomaMalnutrition
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 35
Early research (Phase 1)Study completedNCT01598454
What this trial is testing

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Who this might be right for
NeuroblastomaEwing's SarcomaWilm's Tumor+2 more
Laboratorio Elea Phoenix S.A. 15
Early research (Phase 1)UnknownNCT04595994
What this trial is testing

Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma

Who this might be right for
Sarcoma,Soft Tissue
Grupo Espanol de Investigacion en Sarcomas 14
Testing effectiveness (Phase 2)UnknownNCT04447274
What this trial is testing

Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Who this might be right for
Sarcoma
Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)UnknownNCT02587169
What this trial is testing

Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum

Who this might be right for
Retroperitoneal LiposarcomaRetroperitoneal LeiomyosarcomaChondrosarcoma
Broto, Javier Martín, M.D. 40
Early research (Phase 1)Looking for participantsNCT07052383
What this trial is testing

Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas

Who this might be right for
OsteosarcomaSoft Tissue Sarcoma
Tcelltech Inc. 15
Early research (Phase 1)Study completedNCT00003750
What this trial is testing

Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors

Who this might be right for
Melanoma (Skin)NeuroblastomaSarcoma+1 more
Children's Oncology Group 28
Not applicableStudy completedNCT00954473
What this trial is testing

Study of Blood Samples From Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma
Children's Oncology Group 1,000
Testing effectiveness (Phase 2)Study completedNCT01861951
What this trial is testing

A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Hannover Medical School 120
Not applicableStudy completedNCT01480518
What this trial is testing

Biomarkers in Tissue Samples From Patients With Ewing Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 166
Testing effectiveness (Phase 2)Study completedNCT00204620
What this trial is testing

Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)

Who this might be right for
Sarcoma, Soft Tissue
University Hospital Tuebingen 28
Not applicableStudy completedNCT03768076
What this trial is testing

An Istitution Experience on Parosteal OsTeosarcoma

Who this might be right for
Parosteal Osteosarcoma
Istituto Ortopedico Rizzoli 220
Not applicableUnknownNCT06165718
What this trial is testing

Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.

Who this might be right for
Pulmonary Artery Sarcoma
China-Japan Friendship Hospital 120
Not applicableUnknownNCT05548179
What this trial is testing

Exploring Clinical Trial Experiences of People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Power Life Sciences Inc. 500
Early research (Phase 1)Looking for participantsNCT04715191
What this trial is testing

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Who this might be right for
Liver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more
Baylor College of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT04365660
What this trial is testing

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Who this might be right for
Osteosarcoma
Davidzon, Guido, M.D. 1
Testing effectiveness (Phase 2)Study completedNCT01566123
What this trial is testing

Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)

Who this might be right for
Retroperitoneal Soft Tissue Sarcoma
University Hospital Heidelberg 37
Testing effectiveness (Phase 2)Looking for participantsNCT06052618
What this trial is testing

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Who this might be right for
KSHV Inflammatory Cytokine Syndrome (KICS)Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
National Cancer Institute (NCI) 75
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Not applicableLooking for participantsNCT05231655
What this trial is testing

Ex VIvo DEtermiNed Cancer Therapy

Who this might be right for
Bladder CancerKidney CancerMelanoma+3 more
Sheffield Teaching Hospitals NHS Foundation Trust 600
Next Page